RNA Avidity Biosciences, Inc. - Common Stock
$13,16
Cena · Sie 19, 2026
Dane fundamentalne na dzień Lut 23, 2026
Zakres 52 tyg.
$11–$73
3% of range
Ocena Analityków
BUY
7 analysts
Cena Docelowa
$25
+90% upside
P/E (TTM)
-2.6
ROE
-47.5%
Marża Zysku Netto
-3650.4%
RNA Migawka akcji Cena, kapitalizacja rynkowa, P/E, EPS, ROE, zadłużenie/kapitał własny, zakres 52-tygodniowy
Cena
$13.16
Kapitalizacja Rynkowa
$1.99B
P/E (TTM)
-2.6
EPS (TTM)
$-4.97
Przychody (TTM)
$19M
Stopa dywidendy
—
ROE
-47.5%
D/E Dług/Kapitał
—
Zakres 52 tyg.
$11 – $73
RNA Wykres ceny akcji Dzienny OHLCV ze wskaźnikami technicznymi — przesuwaj, powiększaj i dostosowuj widok
Configure
Wyniki 10-letnie Trendy przychodów, zysku netto, marż i EPS
Przychody i Zysk Netto
$19M
2018-12-31
→
2025-12-31
EPS
$-4.97
2020-12-31
→
2025-12-31
Wolny przepływ pieniężny
$-664M
2020-12-31
→
2025-12-31
Marże
-3650.4%
Wycena Wskaźniki P/E, P/S, P/B, EV/EBITDA — czy akcje są drogie, czy tanie?
Wskaźnik
Trend 5-letni
RNA
Mediana porównawcza
P/E (TTM)
-2.6
—
P/S (TTM)
106.1
9.5
P/B
1.2
1.1
Price / FCF (Cena / FCF)
-3.0
—
Rentowność Marże brutto, operacyjne i netto; ROE, ROA, ROIC
Wskaźnik
Trend 5-letni
RNA
Mediana porównawcza
Operating Margin (Marża Operacyjna)
-3977.3%
—
Net Profit Margin (Marża Zysku Netto)
-3650.4%
-348.2%
ROA
-38.9%
-40.7%
ROE
-47.5%
-49.8%
ROIC
-44.2%
—
Zdrowie finansowe Dług, płynność, wypłacalność — siła bilansu
Wskaźnik
Trend 5-letni
RNA
Mediana porównawcza
Current Ratio (Wskaźnik bieżący)
9.2
12.1
Quick Ratio (Wskaźnik Szybkości)
2.0
—
Rozwój Wzrost przychodów, EPS i zysku netto: r/r, CAGR 3-letni, CAGR 5-letni
Wskaźnik
Trend 5-letni
RNA
Mediana porównawcza
Revenue YoY (Przychody R/R)
72.1%
—
Revenue CAGR 3Y (Przychody CAGR 3L)
26.7%
—
Revenue CAGR 5Y (Przychody CAGR 5L)
22.5%
—
Efektywność kapitałowa Rotacja aktywów, rotacja zapasów, rotacja należności
Wskaźnik
Trend 5-letni
RNA
Mediana porównawcza
RNA Konsensus analityków Bycze i niedźwiedzie opinie analityków, 12-miesięczny cel cenowy, potencjał wzrostu
KUP
7 analityków
- Mocne kupno 2 28,6%
- Kup 4 57,1%
- Trzymaj 1 14,3%
- Sprzedaj 0 0,0%
- Mocna sprzedaż 0 0,0%
12-miesięczny cel cenowy
4 analityków · 2026-08-19
Niski
$25.00
Wysoki
$25.00
Średni cel
$25.00
+90,0%
Średnia cel
$25.00
+90,0%
Historia zysków EPS faktyczny vs szacowany, zaskoczenie %, wskaźnik trafień, data następnych wyników
Średnie zaskoczenie
0.09%
| Okres | EPS Actual | EPS Szacowany | Niespodzianka |
|---|---|---|---|
| 31 marca 2026 | $-0.97 | $-1.06 | 0.09% |
Porównanie z porównywalnymi firmami (podbranża GICS) Kluczowe metryki w porównaniu do konkurentów z sektora
| Ticker | Kapitalizacja Rynkowa | P/E | Przychody r/r | Marża Netto | ROE | Marża brutto |
|---|---|---|---|---|---|---|
| RNA | $10.91B | -14.5 | 72.1% | -3650.4% | -47.5% | — |
| EBS | $644M | 13.3 | -28.8% | 7.1% | 9.9% | — |
| ARCT | $174M | -2.6 | -46.1% | -80.2% | -29.6% | — |
| NBP | — | — | — | — | — | — |
| IMUX | — | -0.9 | — | — | — | — |
| ORGO | $658M | 34.5 | 17.0% | 6.6% | 13.9% | — |
| NERV | $174M | -0.1 | — | — | 339.5% | — |
| IVVD | $697M | -8.2 | 110.5% | -98.2% | -36.9% | — |
| TNXP | $200M | -1.1 | 29.8% | -946.2% | -60.0% | — |
| WHWK | $114M | -7.3 | -72.5% | -288.3% | -13.4% | — |
| PEPG | $448M | -3.1 | — | — | -82.0% | — |
Pełne podstawowe wskaźniki Wszystkie wskaźniki roczne — rachunek zysków i strat, bilans, przepływy pieniężne
Rachunek zysków i strat 15
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $19M | $11M | $10M | $9M | $9M | $7M | $2M | |
| R&D Expense | $559M | $304M | $191M | $150M | $101M | $38M | $15M | |
| SG&A Expense | $206M | $86M | $54M | $38M | $26M | $13M | $5M | |
| Operating Expenses | $765M | $390M | $245M | $188M | $127M | $51M | $20M | |
| Operating Income | $-746M | $-379M | $-236M | $-179M | $-118M | $-44M | $-17M | |
| Interest Expense | · | · | · | $0 | $0 | $209.0K | $7M | |
| Other Non-op | $-2M | $-248.0K | $-594.0K | $-57.0K | $-62.0K | $-75.0K | $0 | |
| Pretax Income | $-685M | $-322M | $-212M | · | · | · | · | |
| Income Tax | $0 | $0 | $0 | $0 | $0 | $0 | $0 | |
| Net Income | $-685M | $-322M | $-212M | $-174M | $-118M | $-44M | $-25M | |
| EPS (Basic) | $-4.97 | $-2.89 | $-2.91 | $-3.34 | $-2.85 | $-2.05 | · | |
| EPS (Diluted) | $-4.97 | $-2.89 | $-2.91 | $-3.34 | $-2.85 | $-2.05 | · | |
| Shares (Basic) | 137,710,000 | 111,582,000 | 73,012,000 | 52,162,000 | 41,428,000 | 21,663,000 | · | |
| Shares (Diluted) | 137,710,000 | 111,582,000 | 73,012,000 | 52,162,000 | 41,428,000 | 21,663,000 | · | |
| EBITDA | $-746M | $-379M | $-236M | $-179M | $-118M | $-44M | · |
Bilans 24
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $383M | $220M | $185M | $340M | $320M | $321M | $95M | |
| Short-term Investments | · | · | · | · | $85M | $7M | · | |
| Receivables | · | $0 | $1M | $2M | · | · | · | |
| Prepaid Expense | $102M | $41M | $16M | $12M | $6M | · | · | |
| Other Current Assets | $53M | $19M | · | $2M | · | · | · | |
| Current Assets | $1.80B | $1.54B | $611M | $623M | $411M | $332M | $96M | |
| PP&E (Net) | $23M | $13M | $8M | $6M | $5M | $1M | $631.0K | |
| PP&E (Gross) | $35M | $21M | $14M | $9M | $7M | $3M | $2M | |
| Accum. Depreciation | $12M | $8M | $5M | $3M | $2M | $2M | $2M | |
| Other Non-current Assets | $82M | $521.0K | $301.0K | $598.0K | $599.0K | $47.0K | $600.0K | |
| Total Assets | $1.96B | $1.56B | $629M | $639M | $428M | $334M | $97M | |
| Accounts Payable | $12M | $8M | $9M | $5M | $3M | $8M | $2M | |
| Current Liabilities | $195M | $98M | $81M | $52M | $30M | $15M | $10M | |
| Capital Leases | $45M | $3M | $6M | $8M | $10M | $938.0K | $393.0K | |
| Other Non-current Liabilities | · | · | · | · | · | · | $45.0K | |
| Total Liabilities | $269M | $139M | $128M | $61M | $46M | $28M | $28M | |
| Long-term Debt | · | · | · | · | · | · | $5M | |
| Common Stock | $15.0K | $12.0K | $8.0K | $7.0K | $5.0K | $4.0K | $0 | |
| Paid-in Capital | · | · | · | $939M | $566M | $373M | $-43M | |
| Retained Earnings | $-1.58B | $-893M | $-571M | $-359M | $-185M | $-67M | $-22M | |
| AOCI | $3M | $3M | $125.0K | $-3M | $-187.0K | $-5.0K | · | |
| Stockholders' Equity | $1.69B | $1.42B | $501M | $578M | $381M | $306M | $-65M | |
| Liabilities + Equity | $1.96B | $1.56B | $629M | $639M | $428M | $334M | $97M | |
| Shares Outstanding | 151,205,000 | 119,893,000 | 79,275,000 | 69,768,000 | 47,754,000 | 37,569,000 | 2,989,000 |
Przepływy pieniężne 10
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $98M | $51M | $38M | $27M | $17M | $4M | $406.0K | |
| Operating Cash Flow | $-650M | $-301M | $-119M | $-136M | $-95M | $-37M | $2M | |
| CapEx | $13M | $7M | $4M | $3M | $4M | $1M | $235.0K | |
| Investing Cash Flow | $-38M | $-854M | $-130M | $-190M | $-83M | $-8M | $-235.0K | |
| Net Debt Issued | · | · | · | $0 | $0 | $-5M | · | |
| Stock Issued | $837M | $762M | $61M | $345M | $175M | $274M | · | |
| Net Stock Activity | $837M | $762M | $61M | $345M | $20M | · | · | |
| Financing Cash Flow | $851M | $1.19B | $94M | $346M | $176M | $272M | $89M | |
| Net Change in Cash | $163M | $37M | $-155M | $20M | $-1M | $227M | $91M | |
| Free Cash Flow | $-664M | $-308M | $-123M | $-139M | $-99M | $-38M | · |
Rentowność 7
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Operating Margin | -3977.3% | -3477.4% | -2464.4% | -1939.6% | -1265.8% | -652.4% | · | |
| Net Margin | -3650.4% | -2957.7% | -2219.9% | -1886.3% | -1265.4% | -653.5% | · | |
| Pretax Margin | -3650.4% | · | · | · | · | · | · | |
| EBITDA Margin | -3977.3% | -3477.4% | -2464.4% | -1939.6% | -1265.8% | -652.4% | · | |
| ROA | -38.9% | -29.4% | -33.5% | -32.6% | -31.0% | -20.6% | · | |
| ROE | -47.5% | -22.0% | -41.7% | -36.4% | -30.4% | -14.2% | · | |
| ROIC | -44.2% | · | · | · | · | · | · |
Płynność i wypłacalność 3
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Current Ratio | 9.2 | 15.7 | 7.6 | 12.0 | 13.9 | 22.7 | · | |
| Quick Ratio | 2.0 | 2.2 | 2.3 | 6.6 | 13.7 | 22.5 | · | |
| Interest Coverage | · | · | · | · | · | -211.9 | · |
Efektywność 2
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | · | |
| Receivables Turnover | · | 19.7 | 5.5 | · | · | · | · |
Stopy Wzrostu 3
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 72.1% | 14.0% | 3.6% | -1.1% | 37.4% | · | · | |
| Revenue CAGR 3Y | 26.7% | 5.3% | 12.1% | · | · | · | · | |
| Revenue CAGR 5Y | 22.5% | · | · | · | · | · | · |
Wycena (TTM) 10
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $19M | $11M | $10M | $9M | $9M | $7M | · | |
| Net Income TTM | $-685M | $-322M | $-212M | $-174M | $-118M | $-44M | · | |
| Market Cap | $10.91B | $3.49B | $717M | $1.55B | $1.14B | $959M | · | |
| P/E | -14.5 | -10.1 | -3.1 | -6.6 | -8.3 | -12.4 | · | |
| P/S | 581.5 | 319.9 | 75.0 | 167.8 | 121.7 | 141.3 | · | |
| P/B | 6.5 | 2.4 | 1.4 | 2.7 | 3.0 | 3.1 | · | |
| P / Tangible Book | 6.5 | 2.4 | 1.4 | 2.7 | 3.0 | 3.1 | · | |
| P / Cash Flow | -16.8 | -11.6 | -6.0 | -11.4 | -12.0 | -25.8 | · | |
| P / FCF | -16.4 | -11.3 | -5.8 | -11.1 | -11.5 | -25.1 | · | |
| Earnings Yield | -6.9% | -9.9% | -32.1% | -15.0% | -12.0% | -8.0% | · |
Rachunek zysków i strat 12
| Wskaźnik | Trend | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $860.0K | $12M | $4M | $2M | $3M | $2M | $2M | $4M | $2M | $3M | $2M | $2M | $3M | $2M | $2M | $2M | |
| R&D Expense | $167M | $155M | $138M | $99M | $96M | $77M | $64M | $67M | $53M | $48M | $43M | $48M | $46M | $37M | $40M | $28M | |
| SG&A Expense | $89M | $46M | $37M | $34M | $28M | $23M | $21M | $14M | $16M | $14M | $12M | $12M | $10M | $10M | $9M | $9M | |
| Operating Expenses | $255M | $201M | $175M | $133M | $124M | $100M | $85M | $81M | $69M | $61M | $55M | $60M | $56M | $47M | $48M | $36M | |
| Operating Income | $-254M | $-189M | $-171M | $-132M | $-121M | $-98M | $-83M | $-77M | $-67M | $-59M | $-53M | $-58M | $-53M | $-45M | $-46M | $-34M | |
| Other Non-op | $-477.0K | $-380.0K | $-651.0K | $-435.0K | $201.0K | $-232.0K | $-116.0K | $-101.0K | $-105.0K | $-13.0K | $-162.0K | $-314.0K | $-18.0K | $-12.0K | $-2.0K | $-25.0K | |
| Net Income | $-237M | $-174M | $-157M | $-116M | $-102M | $-80M | $-71M | $-69M | $-60M | $-52M | $-47M | $-52M | $-50M | $-44M | $-46M | $-34M | |
| EPS (Basic) | $-1.59 | $-1.27 | $-1.21 | $-0.90 | $-0.80 | $-0.65 | $-0.65 | $-0.79 | $-0.80 | $-0.71 | $-0.66 | $-0.74 | $-0.89 | $-0.82 | $-0.92 | $-0.71 | |
| EPS (Diluted) | $-1.59 | $-1.27 | $-1.21 | $-0.90 | $-0.80 | $-0.65 | $-0.65 | $-0.79 | $-0.80 | $-0.71 | $-0.66 | $-0.74 | $-0.89 | $-0.82 | $-0.92 | $-0.71 | |
| Shares (Basic) | -259,039,000 | 137,895,000 | 129,622,000 | 129,232,000 | -205,933,000 | 123,375,000 | 106,928,000 | 87,212,000 | -142,908,000 | 74,097,000 | 71,390,000 | 70,433,000 | -99,080,000 | 53,069,000 | 49,927,000 | 48,246,000 | |
| Shares (Diluted) | -259,039,000 | 137,895,000 | 129,622,000 | 129,232,000 | -205,933,000 | 123,375,000 | 106,928,000 | 87,212,000 | -142,908,000 | 74,097,000 | 71,390,000 | 70,433,000 | -99,080,000 | 53,069,000 | 49,927,000 | 48,246,000 | |
| EBITDA | · | $-189M | $-171M | $-132M | · | $-98M | $-83M | $-77M | · | $-59M | $-53M | $-58M | · | $-45M | · | $-34M |
Bilans 21
| Wskaźnik | Trend | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $383M | $350M | $244M | $254M | $220M | $370M | $576M | $471M | · | $86M | $154M | $119M | · | $144M | $125M | $139M | |
| Short-term Investments | · | · | · | · | · | · | · | · | · | · | · | · | · | $262M | $273M | $258M | |
| Receivables | · | · | · | · | · | $0 | $0 | $2M | · | · | $1M | · | · | · | · | · | |
| Prepaid Expense | $102M | $90M | $67M | $55M | $41M | $33M | $30M | $19M | · | · | $11M | · | · | · | · | · | |
| Other Current Assets | $53M | $60M | $43M | · | $19M | · | · | · | · | · | $6M | · | · | · | · | · | |
| Current Assets | $1.80B | $1.97B | $1.25B | $1.43B | $1.54B | $1.62B | $1.33B | $934M | · | $555M | $595M | $597M | · | $414M | $404M | $405M | |
| PP&E (Net) | $23M | $22M | $21M | $16M | $13M | $9M | $8M | $9M | · | $8M | $8M | $8M | · | $6M | $6M | $5M | |
| PP&E (Gross) | $35M | $32M | $30M | $24M | $21M | $17M | $15M | $15M | · | $13M | $12M | $11M | · | $9M | $9M | $7M | |
| Accum. Depreciation | $12M | $10M | $10M | $9M | $8M | $7M | $7M | $6M | · | $5M | $4M | $4M | · | $3M | $2M | $2M | |
| Other Non-current Assets | $82M | $91M | $91M | $739.0K | $521.0K | $318.0K | $364.0K | $425.0K | · | $344.0K | $424.0K | $474.0K | · | $523.0K | $415.0K | $548.0K | |
| Total Assets | $1.96B | $2.13B | $1.37B | $1.46B | $1.56B | $1.64B | $1.35B | $951M | · | $573M | $611M | $614M | · | $431M | $421M | $421M | |
| Accounts Payable | $12M | $10M | $4M | $7M | $8M | $8M | $9M | $2M | · | $6M | $6M | $4M | · | $26M | $21M | $19M | |
| Current Liabilities | $195M | $170M | $135M | $85M | $98M | $91M | $84M | $75M | · | $49M | $45M | $48M | · | $43M | $34M | $31M | |
| Capital Leases | $45M | $46M | $1M | $2M | $3M | $4M | $5M | $5M | · | $7M | $6M | $7M | · | $8M | $9M | $9M | |
| Total Liabilities | $269M | $248M | $176M | $130M | $139M | $137M | $126M | $121M | · | $56M | $52M | $55M | · | $54M | $46M | $45M | |
| Common Stock | $15.0K | $15.0K | $12.0K | $12.0K | $12.0K | $12.0K | $11.0K | $10.0K | · | $7.0K | $7.0K | $7.0K | · | $5.0K | $5.0K | $5.0K | |
| Retained Earnings | $-1.58B | $-1.34B | $-1.17B | $-1.01B | $-893M | $-791M | $-710M | $-640M | · | $-510M | $-458M | $-411M | · | $-308M | $-264M | $-219M | |
| AOCI | $3M | $2M | $2M | $3M | $3M | $7M | $-453.0K | $-464.0K | · | $-2M | $-3M | $-2M | · | $-3M | $-3M | $-2M | |
| Stockholders' Equity | $1.69B | $1.89B | $1.19B | $1.33B | $1.42B | $1.50B | $1.22B | $831M | $501M | $517M | $559M | $559M | $578M | $377M | $374M | $376M | |
| Liabilities + Equity | $1.96B | $2.13B | $1.37B | $1.46B | $1.56B | $1.64B | $1.35B | $951M | · | $573M | $611M | $614M | · | $431M | $421M | $421M | |
| Shares Outstanding | 151,205,000 | 146,771,000 | 120,778,000 | 120,512,000 | 119,893,000 | 118,900,000 | 109,266,000 | 95,594,000 | 79,275,000 | 74,101,000 | 74,070,000 | 70,813,000 | 69,768,000 | 54,446,000 | 52,081,000 | 49,281,000 |
Przepływy pieniężne 9
| Wskaźnik | Trend | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $43M | $19M | $18M | $18M | $14M | $14M | $13M | $10M | $10M | $10M | $9M | $9M | $7M | $7M | $7M | $6M | |
| Operating Cash Flow | $-170M | $-156M | $-200M | $-125M | $-100M | $-66M | $-65M | $-70M | $17M | $-37M | $-50M | $-49M | $-39M | $-32M | $-36M | $-30M | |
| CapEx | $6M | $712.0K | $3M | $4M | $4M | $2M | $531.0K | $915.0K | $863.0K | $923.0K | $622.0K | $2M | $850.0K | $-107.0K | $1M | $758.0K | |
| Investing Cash Flow | $207M | $-588M | $185M | $157M | $-64M | $-482M | $-275M | $-33M | $51M | $-31M | $46M | $-196M | $-8M | $11M | $-18M | $-175M | |
| Stock Issued | $-538.0K | $837M | $0 | $0 | $-500.0K | $324M | $433M | $6M | $0 | $0 | $38M | $22M | $243M | $39M | $38M | $24M | |
| Net Stock Activity | · | · | · | $0 | · | · | · | $6M | · | · | · | $22M | · | · | · | $24M | |
| Financing Cash Flow | $-5M | $850M | $4M | $2M | $14M | $342M | $447M | $389M | $32M | $40.0K | $39M | $23M | $244M | $40M | $39M | $24M | |
| Net Change in Cash | $32M | $106M | $-10M | $34M | $-150M | $-206M | $107M | $286M | $99M | $-68M | $35M | $-222M | $197M | $19M | $-14M | $-181M | |
| Free Cash Flow | · | · | · | $-129M | · | · | · | $-71M | · | · | · | $-51M | · | · | · | $-30M |
Rentowność 5
| Wskaźnik | Trend | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | · | -1513.5% | -4448.7% | -8360.9% | · | -4200.9% | -4040.4% | -2178.6% | · | -2080.4% | -2272.6% | -2579.3% | · | -1810.2% | · | -1919.8% | |
| Net Margin | · | -1398.3% | -4089.3% | -7360.0% | · | -3441.7% | -3461.8% | -1943.4% | · | -1858.0% | -2030.4% | -2346.3% | · | -1756.6% | · | -1907.2% | |
| EBITDA Margin | · | -1513.5% | -4448.7% | -8360.9% | · | -4200.9% | -4040.4% | -2178.6% | · | -2080.4% | -2272.6% | -2579.3% | · | -1810.2% | · | -1919.8% | |
| ROA | · | -9.2% | -11.6% | -9.6% | · | -7.3% | -7.2% | -8.8% | · | -10.4% | -9.1% | -10.1% | · | -10.2% | · | -9.3% | |
| ROE | · | -10.3% | -13.0% | -10.7% | · | -8.0% | -8.0% | -9.9% | · | -11.7% | -10.1% | -11.2% | · | -11.3% | · | -10.3% |
Płynność i wypłacalność 2
| Wskaźnik | Trend | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | · | 11.6 | 9.3 | 16.9 | · | 17.8 | 15.8 | 12.5 | · | 11.4 | 13.1 | 12.4 | · | 9.7 | · | 13.1 | |
| Quick Ratio | · | 2.1 | 1.8 | 3.0 | · | 4.1 | 6.8 | 6.3 | · | 1.8 | 3.4 | 2.5 | · | 9.5 | · | 12.8 |
Efektywność 2
| Wskaźnik | Trend | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | · | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | · | 0.0 | |
| Receivables Turnover | · | · | · | · | · | · | 3.5 | 4.5 | · | · | 3.9 | · | · | · | · | · |
Wycena (TTM) 10
| Wskaźnik | Trend | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | · | $20M | $10M | $9M | · | $11M | $11M | $11M | · | $10M | $9M | $9M | · | $9M | · | $9M | |
| Net Income TTM | · | $-528M | $-424M | $-336M | · | $-272M | $-239M | $-221M | · | $-195M | $-189M | $-176M | · | $-153M | · | $-114M | |
| Market Cap | · | $6.39B | $3.43B | $3.56B | · | $5.46B | $4.46B | $2.44B | · | $473M | $821M | $1.09B | · | $889M | · | $910M | |
| P/E | · | -10.8 | -8.3 | -9.9 | · | -16.4 | -14.5 | -8.8 | · | -2.2 | -3.5 | -4.8 | · | -5.2 | · | · | |
| P/S | · | 316.1 | 350.0 | 374.6 | · | 508.4 | 416.3 | 223.6 | · | 48.0 | 89.2 | 125.1 | · | 103.2 | · | 98.2 | |
| P/B | · | 3.4 | 2.9 | 2.7 | · | 3.6 | 3.7 | 2.9 | · | 0.9 | 1.5 | 1.9 | · | 2.4 | · | 2.4 | |
| P / Tangible Book | · | 3.4 | 2.9 | 2.7 | · | 3.6 | 3.7 | 2.9 | · | 0.9 | 1.5 | 1.9 | · | 2.4 | · | 2.4 | |
| P / Cash Flow | · | · | · | -28.5 | · | · | · | -34.7 | · | · | · | -22.2 | · | · | · | -30.8 | |
| P / FCF | · | · | · | -27.7 | · | · | · | -34.2 | · | · | · | -21.4 | · | · | · | -30.0 | |
| Earnings Yield | · | -9.2% | -12.0% | -10.1% | · | -6.1% | -6.9% | -11.4% | · | -45.9% | -28.3% | -20.8% | · | -19.2% | · | · |
Sprawozdania finansowe Rachunek zysków i strat, bilans, przepływy pieniężne — roczne, ostatnie 5 lat
Rachunek zysków i strat
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Przychody | $19M | $11M | $10M | $9M | $9M |
| Marża Operacyjna % | -3977.3% | -3477.4% | -2464.4% | -1939.6% | -1265.8% |
| Zysk netto | $-685M | $-322M | $-212M | $-174M | $-118M |
| Rozwodniony EPS | $-4.97 | $-2.89 | $-2.91 | $-3.34 | $-2.85 |
Bilans
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Wskaźnik bieżący | 9.2 | 15.7 | 7.6 | 12.0 | 13.9 |
| Wskaźnik Szybkości | 2.0 | 2.2 | 2.3 | 6.6 | 13.7 |
Przepływy pieniężne
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Wolny przepływ pieniężny | $-664M | $-308M | $-123M | $-139M | $-99M |
Najnowsze wiadomości Najnowsze nagłówki wspominające o tej firmie
Moje wskaźniki Twoja osobista lista obserwowanych — wybrane wiersze z Pełnych Fundamentów
📊
Wybierz metryki, które są dla Ciebie ważne — kliknij ➕ obok dowolnego wiersza w Pełnych Fundamentach powyżej.
Twój wybór został zapisany i będzie Ci towarzyszył we wszystkich tickerach.
Właściciele instytucjonalni (13F) 20 emitentów · $102.7M łącznie · Na dzień 30 czerwca 2026
Instytucje, które zgłaszają posiadanie tych akcji w swoich kwartalnych zgłoszeniach SEC Form 13F. Tylko pozycje długie; pojedynczy zgłaszający może pojawić się dwukrotnie dla oddzielnych transz opcji. Duże przeciwstawne pozycje put/call zazwyczaj odzwierciedlają działalność market-makingową lub zabezpieczone zapasy, a nie przekonanie kierunkowe.
Aktywność instytucjonalna — Q2 2026 vs poprzedni kwartał
| Nowe pozycje | Zamknięte pozycje | Zwiększone | Zmniejszony | Zmiana liczby akcji netto |
|---|---|---|---|---|
| 0 (0 vs poprzedni kw.) | 1 (-322 vs poprzedni kw.) | 0 (0 vs poprzedni kw.) | 1 (0 vs poprzedni kw.) | -8K |
Porównano z Q1 2026. Zgłoszenia SEC Form 13F są wymagane w ciągu 45 dni od końca kwartału plus krótki bufor dla spóźnionych zgłoszeń — kwartały mieszczące się jeszcze w tym terminie są pomijane na rzecz ostatniej w pełni zgłoszonej pary.
| Instytucja | Wartość | Akcje | % z śledzonych 13F | Typ |
|---|---|---|---|---|
| KRYGER CAPITAL Ltd | $75 398 932 | 1 045 320 | 73,42% | Akcje |
| VANGUARD GROUP INC | $6 863 530 | 95 155 | 6,68% | Akcje |
| EFG Asset Management (North America) Corp. | $6 499 913 | 149 149 | 6,33% | Akcje |
| AXA Investment Managers S.A. | $4 429 239 | 101 658 | 4,31% | Akcje |
| ANGELO GORDON & CO., L.P. | $3 245 850 | 45 000 | 3,16% | Akcje |
| Toroso Investments, LLC | $2 628 417 | 36 440 | 2,56% | Akcje |
| WOLVERINE TRADING, LLC | $1 023 120 | 24 000 | 1,00% | Opcja kupna |
| Orion Portfolio Solutions, LLC | $675 595 | 22 886 | 0,66% | Akcje |
| CIBC WORLD MARKETS CORP | $552 372 | 7 658 | 0,54% | Akcje |
| WOLVERINE TRADING, LLC | $456 141 | 10 700 | 0,44% | Opcja sprzedaży |
| Eisler Capital Management Ltd. | $322 088 | 7 600 | 0,31% | Opcja kupna |
| WOLVERINE TRADING, LLC | $285 493 | 6 697 | 0,28% | Akcje |
| Nuveen Asset Management, LLC | $167 268 | 5 752 | 0,16% | Akcje |
| AlphaQuest LLC | $104 589 | 1 450 | 0,10% | Akcje |
| OLIVER LAGORE VANVALIN INVESTMENT GROUP | $19 572 | 663 | 0,02% | Akcje |
| Lindbrook Capital, LLC | $16 708 | 566 | 0,02% | Akcje |
| COMERICA BANK | $10 956 | 152 | 0,01% | Akcje |
| Byrne Asset Management LLC | $1 372 | 102 | 0,00% | Akcje |
| FTB Advisors, Inc. | $511 | 18 | 0,00% | Akcje |
| Hemington Wealth Management | $0 | 7 | 0,00% | Akcje |
Insiderzy spółki 20 insiderów · 11 dyrektorzy generalni · 9 dyrektorzy
| Insider | Rola | Ostatnia aktywność | Posiadane akcje | Kupna 12m | Sprzedaże 12m | Netto 12m |
|---|---|---|---|---|---|---|
| Sarah Boyce | President and CEO | 27 lutego 2026 D | 0 | 0 | 0 | $0 |
| Michael F Maclean | Chief Financial Officer | 27 lutego 2026 D | 0 | 0 | 0 | $0 |
| Joseph Baroldi | Chief Operating Officer | 2 lutego 2021 A | — | 0 | 0 | $0 |
| Charles Calderaro III | Chief Technical Officer | 27 lutego 2026 D | 0 | 0 | 0 | $0 |
| Kathleen P. Gallagher | Chief Program Officer | 27 lutego 2026 D | 0 | 0 | 0 | $0 |
| Teresa Mccarthy | Chief Human Resources Officer | 27 lutego 2026 D | 0 | 0 | 0 | $0 |
| Michael W. Flanagan | Chief Scientific Officer | 27 lutego 2026 D | 0 | 0 | 0 | $0 |
| Steven George Hughes | Chief Medical Officer | 27 lutego 2026 D | 0 | 0 | 0 | $0 |
| Eric Mosbrooker | Chief Commercial Officer | 27 lutego 2026 D | 0 | 0 | 0 | $0 |
| John B Moriarty | Chief Legal Officer | 27 lutego 2026 D | 0 | 0 | 0 | $0 |
| Jae B. Kim | Chief Medical Officer | 2 lutego 2021 A | — | 0 | 0 | $0 |
| Simona Skerjanec | Dyrektor | 27 lutego 2026 D | 0 | 0 | 0 | $0 |
| Jean Jinsun Kim | Dyrektor | 27 lutego 2026 D | 0 | 0 | 0 | $0 |
| Tamar Thompson | Dyrektor | 27 lutego 2026 D | 0 | 0 | 0 | $0 |
| Noreen Henig | Dyrektor | 27 lutego 2026 D | 0 | 0 | 0 | $0 |
| Troy Edward Wilson | Dyrektor | 27 lutego 2026 D | 0 | 0 | 0 | $0 |
| Edward M. Kaye MD | Dyrektor | 27 lutego 2026 D | 0 | 0 | 0 | $0 |
| Carsten Boess | Dyrektor | 27 lutego 2026 D | 0 | 0 | 0 | $0 |
| LEVIN ARTHUR A | Dyrektor | 27 lutego 2026 D | 0 | 0 | 0 | $0 |
| Roderick Wong, M.D. | — | 16 czerwca 2021 A | — | 0 | 0 | $0 |
Insiderzy z zgłoszeń SEC Form 3/4/5; netto = tylko otwarty rynek P/S
Aktywiści i właściciele 5%+ 1 akcja
Inwestorzy, którzy złożyli SEC Schedule 13D — posiadanie beneficjentów powyżej 5% z zamiarem wpływania na emitenta (udziały aktywistów, kampanie zarządu, M&A). Każdy wiersz pokazuje najnowszy znany stan pozycji tego zgłaszającego.
| Zgłaszający | Złożono | Udział | Status | Cel | Zgłoszenie |
|---|---|---|---|---|---|
| RTW Investments, LP, Roderick Wong ×6 zgłoszenia | 29 października 2025 | 3,10% | Aneks | — | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Posiadanie ETF-ów Posiadane przez 15 funduszy ETF
Waga odzwierciedla wyłącznie bezpośrednie udziały kapitałowe (N-PORT); fundusze oparte na dźwigni lub instrumentach pochodnych mogą posiadać dodatkowe ekspozycje na swapy, które nie są pokazane.
| Fundusz | Waga | Jednostki | Na dzień | Źródło |
|---|---|---|---|---|
| IWC · iShares Trust | 0,04% | 48 184 SH | 8 sierpnia 2026 | Dziennie |
| OMFS · Invesco Exchange-Traded Self-Indexe… | 0,02% | 4 415 SH | 8 sierpnia 2026 | Dziennie |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,01% | 82 327 SH | 8 sierpnia 2026 | Dziennie |
| VTWG · VANGUARD SCOTTSDALE FUNDS | 0,01% | 10 724 SH | 8 sierpnia 2026 | Dziennie |
| IWO · iShares Trust | 0,01% | 85 960 SH | 8 sierpnia 2026 | Dziennie |
| IWM · iShares Trust | 0,01% | 369 738 SH | 8 sierpnia 2026 | Dziennie |
| IWN · iShares Trust | 0,00% | 40 687 SH | 8 sierpnia 2026 | Dziennie |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0,00% | 2 952 SH | 8 sierpnia 2026 | Dziennie |
| IWV · iShares Trust | 0,00% | 3 267 SH | 8 sierpnia 2026 | Dziennie |
| VXF · VANGUARD INDEX FUNDS | 0,00% | 188 626 SH | 8 sierpnia 2026 | Dziennie |
| VTI · VANGUARD INDEX FUNDS | 0,00% | 518 416 SH | 8 sierpnia 2026 | Dziennie |
| VT · VANGUARD INTERNATIONAL EQUITY INDEX… | 0,00% | 8 760 SH | 8 sierpnia 2026 | Dziennie |
| VTWV · VANGUARD SCOTTSDALE FUNDS | 0,00% | 3 882 SH | 8 sierpnia 2026 | Dziennie |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,00% | 933 SH | 8 sierpnia 2026 | Dziennie |
| ESGV · VANGUARD WORLD FUND | 0,00% | 3 329 SH | 8 sierpnia 2026 | Dziennie |